Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2025

Earnings Per Share [Abstract]

Summary of Basic and Diluted Loss Per Share

Basic and diluted loss per share is computed by dividing net loss by the weighted-average common stock outstanding for the period. The Company had 15,159,753 and 11,640,594 pre-funded warrants outstanding as of March 31 2025 and 2024, respectively. Each pre-funded warrant is exercisable for one share of common stock at an exercise price of $0.0001 per share. Due to the nominal exercise price of the pre-funded warrants, they are considered to be outstanding shares of common stock for purposes of the calculation of earnings per share. (in thousands, except for share and per share data):

	Three Months Ended March 31,
	2025			2024
Numerator:
Net loss	$	(65,581	)	$	(48,557	)
Denominator:
Weighted average common shares outstanding, basic and diluted		64,986,778			60,068,921
Weighted average pre-funded warrants outstanding, basic and diluted		15,159,753			10,701,399
Total weighted average common stock outstanding, basic and diluted		80,146,531			70,770,320
Net loss per share:
Net loss per share, basic and diluted	$	(0.82	)	$	(0.69	)

Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders Anti-Diluted Effect

The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders at March 31, 2025 and 2024 because including them would have had an anti-dilutive effect:

	Three Months Ended March 31,
	2025		2024
Unvested restricted stock		1,209,989		725,438
Options to purchase common stock		10,916,487		9,876,714
Total		12,126,476		10,602,152